Jump to main content
Jump to site search
Access to RSC content Close the message box

Continue to access RSC content when you are not at your institution. Follow our step-by-step guide.


Issue 7, 2020
Previous Article Next Article

In vitro anti-diabetic assessment of guavanoic acid functionalized gold nanoparticles in regulating glucose transport using L6 rat skeletal muscle cells

Author affiliations

Abstract

Guavanoic acid functionalized gold nanoparticles exhibit anti-diabetic potential by improving insulin dependent glucose uptake in L6 rat skeletal muscle cells. The mode of action of the gold nanoparticles was established from the glucose uptake assay in the presence and absence of genistein and wortmannin. The anti-diabetic efficacy of guavanoic acid functionalized gold nanoparticles was put forth by in vitro assays like for PTP 1B, α-amylase and α-glucosidase enzyme activities. Studies on cytotoxicity revealed 50% inhibition of cells at 265 ± 0.01 μg mL−1. In the LDH enzyme release assay on differentiated L6 myoblasts treated with different concentrations (1–100 μg mL−1) of guavanoic acid functionalized gold nanoparticles, a viability of 75% at 100 μg mL−1 was observed.

Graphical abstract: In vitro anti-diabetic assessment of guavanoic acid functionalized gold nanoparticles in regulating glucose transport using L6 rat skeletal muscle cells

Back to tab navigation

Article information


Submitted
15 Apr 2020
Accepted
27 Apr 2020
First published
05 Jun 2020

RSC Med. Chem., 2020,11, 814-822
Article type
Research Article

In vitro anti-diabetic assessment of guavanoic acid functionalized gold nanoparticles in regulating glucose transport using L6 rat skeletal muscle cells

K. Govindaraju and K. S. U. Suganya, RSC Med. Chem., 2020, 11, 814
DOI: 10.1039/D0MD00125B

Social activity

Search articles by author

Spotlight

Advertisements